United States · FDA National Drug Code directory
Flecainide Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0012_e34a6adf-8794-426e-9e43-11060803a90d
- Product NDC
- 0054-0012
- Form
- TABLET
- Composition / generic term
- flecainide acetate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20030114
- Source listing expiry
- 20261231
Source-listed ingredients
- FLECAINIDE ACETATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (0054-0012-20) / 1 TABLET in 1 BLISTER PACK · 0054-0012-20
- 60 TABLET in 1 BOTTLE (0054-0012-21) · 0054-0012-21
- 100 TABLET in 1 BOTTLE (0054-0012-25) · 0054-0012-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →